Research guide · Skin & Aesthetic Support
GHK-Cu — research protocol
Copper-binding tripeptide studied for skin regeneration and collagen support.
This guide summarizes study areas and sources associated with the compound. BioPeptideX does not convert experimental information into a clinical regimen or recommend an individual dose, frequency, route or duration.
Catalog presentations
Concentration table
Mathematical reference only; this is not a dosing recommendation.
Research areas
- Copper-binding tripeptide
- Regeneration compound
- Cold-chain handled
Most-cited research protocols
Educational information based on research protocols and literature; it does not replace guidance from a healthcare professional.
GHK-Cu is a naturally occurring copper-binding peptide, with levels decreasing with age. Research and community use are split between topical formulations and subcutaneous injection.
| Dose | Frequency | Duration | Route | |
|---|---|---|---|---|
| SubQ Conservative start | 1.0 mg | 5 days on / 2 off | 4 weeks | Subcutaneous |
| Topical Facial anti-aging (community use) | 1-2% | Once or twice daily | 8-12 weeks | Topical |
| Topical Scalp / hair-research interest | 1-3% | Daily | 12+ weeks ongoing | Topical |
| Topical Compounded post-procedure | 1-2% | Per clinician guidance | Per clinician guidance | Topical |
Cycle: Subcutaneous injections are typically rotated across the abdomen, outer thigh, and back of the upper arm, often with 2-4 week off-periods between cycles.
Benefits and research observations: Topical clinical trials typically measure endpoints at 8-12 weeks for skin firmness, density, and wrinkle depth. Injectable timelines are community-derived, usually 4-8 weeks, for changes in skin or hair quality.
Handling and storage
Store unreconstituted product according to its label and maintain the cold chain where applicable. After any preparation, follow only validated instructions for the specific product and diluent. Do not use if packaging is damaged or the solution shows particles or unexpected changes.
Warnings
Do not use this page for self-diagnosis or self-medication. Pregnancy, breastfeeding, minors, cancer history, allergies, active disease and concurrent treatments require individual professional evaluation.
Published sources
- 1.Pickart L, Margolina A. Int J Mol Sci, 2018.
- 2.Pickart L, et al. Biomed Res Int, 2015.